Evidence map›Paper›PMID 19053057›Full record

ArticleGlia2009

Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.

M R Bryant, C B Marta, F S Kim, R Bansal

Open access · greenAbstract read
In one paragraph

Article in Glia, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M R BryantDepartment of Neuroscience, University of Connecticut Medical School, Farmington, Connecticut 06030-3401, USA.
C B Marta
F S Kim
R Bansal
University of Connecticut · US

Funding

Fibroblast Growth Factor Receptors in Myelin Function and DiseaseR01NS038878 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BANSAL, RASHMI · 1999 to 2012
$3.9M
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINSR01NS041078 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BANSAL, RASHMI · 2000 to 2009
$3.3M
Role of FGF-Signaling in MyelinogenesisR37NS038878 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BANSAL, RASHMI · 2013 to 2019
$2.9M
NINDS NIH HHS NS038878NINDS NIH HHS NS41078NINDS NIH HHS R01 NS038878NINDS NIH HHS R01 NS041078NINDS NIH HHS R37 NS038878
6 · The paper itself

Abstract

Fibroblast growth factors (FGFs) and their receptors (FGFRs) initiate diverse cellular responses that contribute to the regulation of oligodendrocyte (OL) function. To understand the mechanisms by which FGFRs elicit these cellular responses, we investigated the phosphorylation of signal transduction proteins and the role of cholesterol-glycosphingolipid-enriched "lipid raft" microdomains in differentiated OLs. Surprisingly, we found that the most abundant tyrosine-phosphorylated protein in OLs was the 120-kd isoform of FGFR2 and that it was phosphorylated even in the absence of FGF2, suggesting a potential ligand-independent function for this receptor. Furthermore, FGFR2, but not FGFR1, was associated with lipid raft microdomains in OLs and myelin (but not in astrocytes). This provides the first evidence for the association of FGFR with TX-100-insoluble lipid raft fractions. FGFR2 phosphorylated the key downstream target, FRS2 in OLs. Raft disruption resulted in loss of phosphorylated FRS2 from lipid rafts, coupled with the loss of Akt but not of Mek or Erk phosphorylation. This suggests that FGFR2-FRS2 signaling in lipid rafts operates via the PI3-Kinase/Akt pathway rather than the Ras/Mek/Erk pathway, emphasizing the importance of microenvironments within the cell membrane. Also present in lipid rafts in OLs and myelin, but not in astrocytes, was a novel 52-kd isoform of FGFR2 that lacked the extracellular ligand-binding region. These results demonstrate that FGFR2 in OLs and myelin possess unique characteristics that are specific both to receptor type and to OLs and provide a novel mechanism to elicit distinct cellular responses that mediate both FGF-dependent and -independent functions.

Indexed as

AnimalsAstrocytesCells, CulturedExtracellular Signal-Regulated MAP KinasesMAP Kinase Kinase KinasesMembrane MicrodomainsMiceMice, KnockoutMyelin SheathOligodendrogliaPhosphorylationProtein IsoformsProto-Oncogene Proteins c-aktRatsReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 2Extracellular Signal-Regulated MAP KinasesFgfr1 protein, ratFgfr2 protein, mouseFgfr2 protein, ratMAP Kinase Kinase KinasesProtein IsoformsProto-Oncogene Proteins c-aktReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 2Tyrosine

Identifiers

PMID19053057
PMCPMC2682628
OpenAlexW2040622726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.